XPRIZE Healthspan asks competing teams to demonstrate functional improvement in people. Its target is expressed in years of expected age-associated decline, using reference populations and specified tests.
The competition is research infrastructure. It contains multiple interventions, sponsors and trials. Listing the competition as a single successful therapy would conceal the different approaches and the evidence required for each.
XPRIZE announced 20 finalist teams on 11 August 2026, with ten receiving $1 million milestone awards. An older page still displays the earlier 40-team semifinalist group.
- Muscle functionStandard functional assessments.
- Cognitive functionDefined computerised testing.
- Immune functionSpecified assessments under the prize rules.
These are parallel assessment domains. A prize threshold does not measure extra years of life. Sources for this account.
The mechanism
The framework examines muscle, cognitive and immune function. Teams compare their intervention with a control condition, then submit results for assessment under shared rules.
The published guidelines translate a functional change into an equivalent period of expected decline in a reference population. The calculation defines a prize threshold. It does not measure the number of extra years a participant will live.
The finals rules specify standard assessments, including a six-minute walk and lower-body power tests, with computerised cognitive testing. They also separate exploratory biomarker analyses from the principal judging outcomes.
Common measurements can help readers compare trials, but they do not make the interventions interchangeable. A cell therapy and a behavioural programme can carry very different mechanisms, burdens and safety questions even when participants complete the same tests.
Human evidence
The finalists advance into a clinical-testing framework. Selection reflects the organisers' assessment of rationale, readiness and other criteria. It is not a pooled human efficacy result for twenty programmes.
The central data coordinating centre is associated with the University of Utah, with shared laboratory and sample resources coordinated through UC San Diego. These arrangements create a route to more consistent collection and analysis across sites.
Each team's intervention needs its own registry record, protocol, participant characteristics and results. Selection as a finalist does not establish the outcome of that team's trial.
Studies and experimental evidence
XPRIZE Healthspan finals framework
- Design
- Multiple prospective controlled trials under shared competition rules
- Population or model
- Adults aged 50–90 under programme-specific eligibility rules
- Sample size
- Varies by team; rules encourage up to 200 participants
- Comparison
- Placebo, control or standard-of-care condition, depending on intervention
- Duration
- Intervention and assessment within approximately one year
- Outcome
- Functional responder thresholds across muscle, cognition and immunity
No pooled finals efficacy result verified as of 4 October 2026
Prize participation and awards cannot establish efficacy; interventions and populations differ
Funding and interests: Hevolution, SOLVE FSHD and other competition supporters; team funding differs
Development history
Competition launched
The seven-year competition began.
First milestone awards announced
Forty Healthspan teams were selected as milestone winners from the earlier qualifying cohort.
Guidelines version 2.2 released
Revised competition rules increased the upper participant age limit to 90.
Twenty finalists announced
Ten finalists received milestone awards; all twenty advanced.
Unresolved questions
- Which finalist trials have registered complete protocols and begun recruitment?
- How much change exceeds control-group improvement on the shared tests?
- Do improvements persist after the intervention period?
- How sensitive are responder classifications to the chosen reference population?
- Will complete datasets and negative results become publicly accessible?
- What does each intervention cost and require when moved beyond its research setting?
The competition is in its finals stage and states that it culminates in 2030. Individual trial registrations, participant follow-up and released results will show what each intervention achieves.
Sources
- Institutional source · 11 Aug 2026Twenty finalist teams announced; ten receive milestone awards
Dated finalist selection and shared infrastructure.
Checked 4 Oct 2026 - Institutional source · 21 Jan 2026XPRIZE Healthspan competition guidelines v2.2
Explains functional-year targets and reference populations.
Checked 4 Oct 2026 - Institutional source · 13 Apr 2026XPRIZE Healthspan finals rules and regulations
Shared trial design and assessment methods; linked as current finals rules.
Checked 4 Oct 2026 - Institutional source · 12 May 2025First milestone winners announced
Earlier cohort history.
Checked 4 Oct 2026 - Institutional source · UndatedXPRIZE Healthspan current competition page
Current finals status and maintained rule links.
Checked 4 Oct 2026
Dr T Smith, organic chemist and science educator. Review date: 4 Oct 2026. Report a correction.